Literature DB >> 18672048

Induction of cell death by TiO2 nanoparticles: studies on a human monoblastoid cell line.

Carmen I Vamanu1, Mihaela R Cimpan, Paul J Høl, Steinar Sørnes, Stein A Lie, Nils R Gjerdet.   

Abstract

The cellular responses to degradation products from titanium (Ti) implants are important indicators for the biocompatibility of these widely used implantable medical devices. The potential toxicity of nanoparticulate matter released from implants has been scarcely studied. The aim of this study was to investigate the potential of TiO2 nanoparticles to induce modifications characteristic for death by apoptosis and/or necrosis in U937 human monoblastoid cells. Suspensions of TiO2 nanoparticles with a diameter <100nm were prepared in RPMI cell culture medium at concentrations that covered a range (0.005-4mg/ml) corresponding to concentrations found in blood, plasma, or in tissues surrounding Ti implants. The cells were exposed to the nanoparticulate suspensions for 24 and 48h and the responses were evaluated by flow cytometry and transmission electron microscopy. TiO2 nanoparticles induced both apoptotic and necrotic modifications in U937 cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18672048     DOI: 10.1016/j.tiv.2008.07.002

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  23 in total

1.  Cytotoxicity, DNA damage, and apoptosis induced by titanium dioxide nanoparticles in human non-small cell lung cancer A549 cells.

Authors:  Yurong Wang; Haiyan Cui; Jiaping Zhou; Fengjuan Li; Jinju Wang; Mianhua Chen; Qingdai Liu
Journal:  Environ Sci Pollut Res Int       Date:  2014-10-24       Impact factor: 4.223

2.  Molecular responses of mouse macrophages to copper and copper oxide nanoparticles inferred from proteomic analyses.

Authors:  Sarah Triboulet; Catherine Aude-Garcia; Marie Carrière; Hélène Diemer; Fabienne Proamer; Aurélie Habert; Mireille Chevallet; Véronique Collin-Faure; Jean-Marc Strub; Daniel Hanau; Alain Van Dorsselaer; Nathalie Herlin-Boime; Thierry Rabilloud
Journal:  Mol Cell Proteomics       Date:  2013-07-23       Impact factor: 5.911

3.  Biological reactivity of TiO2 nanoparticles assessed by ex vivo testing.

Authors:  Janez Valant; Damjana Drobne
Journal:  Protoplasma       Date:  2011-06-19       Impact factor: 3.356

Review 4.  Diagnostic tests for titanium hypersensitivity in implant dentistry: a systematic review of the literature.

Authors:  Lena Katharina Müller-Heupt; Eik Schiegnitz; Sebahat Kaya; Elisabeth Jacobi-Gresser; Peer Wolfgang Kämmerer; Bilal Al-Nawas
Journal:  Int J Implant Dent       Date:  2022-07-11

Review 5.  Titanium dioxide nanoparticles: a review of current toxicological data.

Authors:  Hongbo Shi; Ruth Magaye; Vincent Castranova; Jinshun Zhao
Journal:  Part Fibre Toxicol       Date:  2013-04-15       Impact factor: 9.400

6.  Effects of serum on cytotoxicity of nano- and micro-sized ZnO particles.

Authors:  I-Lun Hsiao; Yuh-Jeen Huang
Journal:  J Nanopart Res       Date:  2013-08-27       Impact factor: 2.253

7.  Titanium dioxide in our everyday life; is it safe?

Authors:  Matej Skocaj; Metka Filipic; Jana Petkovic; Sasa Novak
Journal:  Radiol Oncol       Date:  2011-11-16       Impact factor: 2.991

Review 8.  Activation of neutrophils by nanoparticles.

Authors:  David M Goncalves; Rafael de Liz; Denis Girard
Journal:  ScientificWorldJournal       Date:  2011-10-24

9.  Long-Term Exposure to Nanosized TiO2 Triggers Stress Responses and Cell Death Pathways in Pulmonary Epithelial Cells.

Authors:  Mayes Alswady-Hoff; Johanna Samulin Erdem; Santosh Phuyal; Oskar Knittelfelder; Animesh Sharma; Davi de Miranda Fonseca; Øivind Skare; Geir Slupphaug; Shanbeh Zienolddiny
Journal:  Int J Mol Sci       Date:  2021-05-19       Impact factor: 5.923

10.  Health effects of exposure to nano-TiO2: a meta-analysis of experimental studies.

Authors:  Xuhong Chang; Yu Zhang; Meng Tang; Bei Wang
Journal:  Nanoscale Res Lett       Date:  2013-01-25       Impact factor: 4.703

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.